Efficacy and Safety of MT10107 (Coretox) in Poststroke Upper Limb Spasticity Treatment: A Randomized, Double-Blind, Active Drug-Controlled, Multicenter, Phase III Clinical Trial
2020 ◽
Vol 101
(9)
◽
pp. 1485-1496
Keyword(s):